Delavau Pharmaceutical Partners

What Delavau Pharmaceutical Partners does

Delavau Pharmaceutical Partners is a privately held U.S. pharmaceutical services company headquartered in Philadelphia, Pennsylvania. According to the firmographic record, the company was founded in 1847 and operates with a workforce of 101-250 employees. Its stated offering is tableting and packaging services for the pharmaceutical industry, placing it in the contract development and manufacturing organization (CDMO) / contract packaging segment of the pharma value chain. The company maintains a corporate web presence at delavau.com and is classified as a for-profit, non-public entity.

The available input does not provide additional detail on Delavau's specific product lines, technology platforms, manufacturing capacity, regulatory certifications, customer roster, pricing model, or revenue mechanics. The narrative source material supplied in this record describes SBOBET88, an Indonesian online sports betting and casino platform, and contains no verifiable information about Delavau Pharmaceutical Partners' operations, financials, customers, or strategic activities. As a result, this description is necessarily limited to the firmographic snapshot; any deeper claims about products, technology stack, business model mechanics, or go-to-market approach would not be grounded in the input data and have been omitted.

Name

Delavau Pharmaceutical Partners

Legal name

SBOBET INDONESIA

Website

https://delavau.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

101–250 employees

Short description

Delavau Pharmaceutical Partners is a Philadelphia-based, privately held pharmaceutical company founded in 1847 that provides tableting and packaging services to the pharmaceutical industry with 101-250 employees.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

Keywords

• Pharmaceutical manufacturing
• Tablet compression services
• Pharmaceutical packaging
• Contract manufacturing services
• Solid dose manufacturing

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain

Pricing tiers

Distribution channels4 records

Marketing channels2 records

Core offering

Delavau Pharmaceutical Partners is a Philadelphia-based pharmaceutical company that provides tableting and packaging services. The firm operates as a contract manufacturer offering solid-dose production and packaging capabilities to pharmaceutical clients.

Differentiator

Problem solved

Functional benefit

Products and services

• Tableting and Packaging Services Contract pharmaceutical manufacturing services encompassing tablet compression production and packaging of solid-dose drug products, offered to pharmaceutical brand owners and developers requiring outsourced manufacturing capacity.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• First Cagayan Leisure & Resort CorporationcoreOEM/ Whitelabel/ Licensing Partner · 1 January 2010Licensed by First Cagayan Leisure & Resort Corporation to operate and serve players across Asia as a SBOBET representative. The company has operated as a trusted SBOBET and SBOBET88 representative in Indonesia since 2010.

Direct peers

• Catalent: One of the largest global CDMOs with extensive oral solid-dose manufacturing and packaging capabilities. Directly comparable to Delavau as a contract tableting and packaging services provider, albeit at materially larger scale.
• CoreRx: Mid-sized US CDMO specializing in solid oral dosage form development, manufacturing, and packaging. Closely mirrors Delavau's service mix at a comparable small-to-mid scale.
• Halo Pharmaceutical: US-based CDMO offering formulation development, commercial manufacturing, and packaging for oral solids. Directly comparable to Delavau on service offering and customer profile of small-to-mid pharma.
• Quotient Sciences: CDMO providing formulation, manufacturing, and clinical packaging services for oral drug products. Comparable to Delavau in the integrated development-to-supply value chain for solid dose forms.
• Contract Pharmaceuticals Limited: Canadian-based CDMO specializing in liquid and semi-solid pharmaceutical manufacturing and packaging. Comparable as a mid-sized contract manufacturer providing complementary dosage-form services to the same small/mid pharma customer base as Delavau.
• Particle Sciences (Lubrizol Life Science): CDMO specializing in complex drug delivery and contract manufacturing for solid, semi-solid, and injectable dosage forms. Comparable to Delavau as a development-and-manufacturing partner for small-to-mid pharma sponsors.

Broad incumbents

• Patheon (Thermo Fisher Scientific): Operates a major pharma services network within Thermo Fisher offering drug substance, drug product, and packaging services. Comparable to Delavau across the tableting and packaging service stack, though as part of a much broader portfolio.
• Aenova Group: One of Europe's largest pharmaceutical CDMOs, providing solid and semi-solid dosage form development, manufacturing, and packaging. Comparable to Delavau on integrated CDMO services at significantly larger scale and broader geographic reach.

Emerging players

• Aprecia Pharmaceuticals: Specialty CDMO with proprietary 3D-printing technology for oral dosage forms. Comparable as a niche contract manufacturer serving pharma sponsors with differentiated solid-dose offerings, though focused on a unique technology platform.

Regional players

• Hermes Pharma: European CDMO offering granulation, tableting, and packaging of oral solid dose forms, including effervescent and chewable formats. Comparable to Delavau on core service capability but primarily serves European sponsors.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/delavau-llc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Delavau Pharmaceutical Partners